Organization
RBP4
2 clinical trials
Clinical trial
Phase 1/2, Open-Label, Dose-Finding Followed by 2-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt DiseaseStatus: Completed, Estimated PCD: 2023-08-15
Clinical trial
A Phase 1b, Open-Label, Parallel Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Tinlarebant in Healthy Volunteers Aged 50-85Status: Completed, Estimated PCD: 2023-01-04